甲状腺发育不良所致先天性甲状腺功能减退症的双基因遗传模式:HYPOTYGEN转化队列研究
法国全国性前瞻性多中心转化研究纳入514例经新生儿筛查确诊的先天性甲状腺功能减退症(CH)患者,聚焦甲状腺发育不良(CHTD)的临床与分子表型。对292例患者行78基因靶向二代测序,20/292(6.8%)检出已知CHTD基因的致病突变,16例(5.5%)携带甲状腺发育基因与H2O2生成复合体基因DUOX2/DUOXA2各一个变异,家系分离与体外功能研究支持双基因遗传模式。
要点
- 514例CH筛查确诊患者中,458例分析临床表型,心脏畸形7.7%(14/182)、肾脏畸形3.9%(7/178)。
- 292例行78基因靶向测序,20/292(6.8%)检出已知CHTD基因致病突变。
- 16例(5.5%)为双基因遗传:甲状腺发育基因变异合并DUOX2/DUOXA2变异。
核心结论
- 本研究通过证明甲状腺发育基因与DUOX2/DUOXA2基因的有害变异可共同参与CHTD的双基因遗传,扩展了对CHTD分子病因的认识。
- 该模式的复杂性意味着需修订CHTD的遗传格局,并在长期随访中给予患者特定的临床照护。
研究设计与样本
- 法国全国性前瞻性多中心转化研究(HYPOTYGEN队列),纳入514例经系统新生儿筛查确诊的CH患者。
- 聚焦CHTD病例,研究其临床与分子表型;采用包含78个基因的靶向二代测序面板,覆盖甲状腺发育、功能、转运、代谢及甲状腺激素作用相关基因。
- 进行了统计分析、家系分离分析及聚焦细胞迁移的体外功能研究。
- 对458例CH患者分析临床表型;基于种族及先证者与其父母DNA样本可及性标准,对队列中292例患者行遗传分析。
主要发现
- 心脏畸形见于7.7%(14/182)的患者,肾脏畸形见于3.9%(7/178)的患者。
- 292例接受遗传分析的患者中,20/292(6.8%)检出10个已知CHTD基因中1个基因的致病突变。
- 16例(5.5%)患者呈双基因遗传模式,每人携带一个甲状腺发育基因变异和一个H2O2生成复合体基因DUOX2/DUOXA2变异。
- 家系分离分析与体外功能研究支持该双基因遗传模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder and is chiefly caused by thyroid dysgenesis (CHTD). The inheritance mode of the disease remains complex. OBJECTIVE: Gain insight into the inheritance mode of CHTD. METHODS: Prospective multicenter nationwide translational study in France including 514 patients with CH diagnosed through systematic newborn screening (HYPOTYGEN cohort). We focused on CHTD cases and studied their clinical and molecular phenotypes. Targeted next-generation sequencing using a 78-gene panel, including genes involved in thyroid development, function, transport, metabolism and action of thyroid hormones. Statistical analysis, familial segregation, and in vitro functional studies focusing on cell migration have been performed. RESULTS: We analyzed the clinical phenotypes of 458 patients with CH. Cardiac and renal malformations were present in 7.7% (14/182) and 3.9% (7/178) of patients, respectively. Genetic analysis was performed on 292 patients of the cohort, based on criteria for ethnicity and availability of DNA samples for index cases and their parents. A disease-causing mutation in 1 of the 10 known genes for CHTD was identified in 20/292 (6.8%) patients. We found a digenic mode of inheritance in 16 (5.5%) patients, each carrying a variant in a thyroid development gene and a variant in the H2O2 generation complex gene DUOX2/DUOXA2. Familial segregation analysis and in vitro functional studies supported this model. CONCLUSION: This work expands our understanding of the molecular causes of CHTD by demonstrating that digenic inheritance can be implicated, with deleterious variants in thyroid development and DUOX2/DUOXA2 genes. The complexity of this model implies a revision of the genetic landscape of CHTD and specific clinical care of patients during long-term follow-up.
引用
- Stoupa A, Kariyawasam D, Jabot-Hanin F, et al. Digenic Inheritance Mode in Congenital Hypothyroidism Due to Thyroid Dysgenesis: HYPOTYGEN Translational Cohort Study. J Clin Endocrinol Metab. 2025. PMID: 39787321. doi:10.1210/clinem/dgaf004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。